The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

6FB4UjsvmAce3pwFc2APkTTmAQbyUPQKWGQw7IjJq9vgdgCrJcdxk8AdCZZ

TSIF Program Application

Returning?

A A A

This form serves as your application for the Translational Science Interagency Fellowship (TSIF) Program. Please complete the following application form and upload all additional required documents (including personal statement, CV, academic transcripts, and FDA Form 4083) by 11:59pm ET February 3, 2025. Incomplete applications will not be considered.

Thank you for your interest in the TSIF Program!

First Name:

* must provide value

Middle Name (if any):

Last Name / Surname:

* must provide value

Date of Birth:

* must provide value

M-D-Y

Preferred email:

* must provide value

Preferred Phone Number:

Citizenship:

* must provide value

U.S. Citizen

U.S. Permanent Resident

Foreign Citizen

reset

Do you currently have a Ph.D., M.D., or other doctoral degree in a related discipline?

* must provide value

Yes

reset

The TSIF fellowship is only open to those who have completed their terminal doctoral degree up to two years before the start year of the fellowship. Did you receive your terminal degree (a Ph.D., M.D., or other doctoral degree in a related discipline) in 2023 or after?

* must provide value

Yes

reset

Will you have a Ph.D., M.D., or other doctoral degree in a related discipline before the start of the fellowship (Sept. 8th, 2025)?

* must provide value

Yes

reset

Please read the FDA Ethics for Non-employee scientists, found here: https://www.fda.gov/about-fda/office-chief-scientist/fda-ethics-non-employee-scientists

I confirm that I have read and understand the FDA Ethics for Nonemployee Scientists requirements.

* must provide value

Add signature

Please select your first choice project:

* must provide value

Developing State-of-the-Art Analytical Methods for the Comparison of Biosimilar Drugs to Related Human Growth Hormones
Mentors: Kan Chen (CDER/FDA), Christopher LeClair (NCATS) and Dingyin Tao (NCATS)

Leveraging AI to Enhance Drug Safety Predictions through Integrated Analysis of Tox21 Data and FDA's Clinical Data
Mentors: Minjun Chen (NCTR/FDA) and Ruili Huang (NCATS)

Enhancing Intestinal Barrier Research through Integrative High-Throughput TEER Analysis and Mechanistic Elucidation for Intestinal Toxicity Screening
Mentors: Sangeeta Khare (NCTR/FDA), Kuppan Gokulan (NCTR/FDA), Xin Xu (NCATS) and Elias Carvalho Padilha (NCATS)

Quantitative high throughput screening for drugs targeting COP1 to promote T cell function.
Mentors: Weiming Ouyang (CDER/FDA) and Menghang Xia (NCATS)

Understanding the implications of codon optimization on the physiochemical and immunogenic properties of truncated-ADAMTS13 (MDTCS) and Niemann-Pick disease
Mentors: Chava Kimchi-Sarfaty (CDER/FDA) , Upendra Katneni (CBER/FDA) and Catherine Chen (NCATS)

Evaluation of three-dimensional (3D) immunocompetent skin fibrosis model for cell-based therapy products
Mentors: Kyung Sung (CBER/FDA), Mark Ferrer (NCATS) and Yi Wei Lim (NCATS)

Development of a defined process for manufacturing iPSC-derived mesenchymal stromal cells producing extracellular vesicles to modulate pericyte function in neurodegenerative disease
Mentors: Ross Marklein (CBER/FDA), Jin Han (CBER/FDA), Carlos Tristan (NCATS)

Developing 3D Bioprinted Outer Blood Retina Barrier Model of Choroideremia Using Patient-derived iPSCs for Assessing Gene Therapy Safety and Efficacy
Mentors: Ronit Mazor (CBER/FDA) ,Zhaohui Ye (CBER/FDA), Sojin Bing and Min Jae Song (NCATS) Collaborators: Ruchi Sharma (NEI) and Kapil Bharti (NEI)

reset

Please select your second choice project:

* must provide value

Leveraging AI to Enhance Drug Safety Predictions through Integrated Analysis of Tox21 Data and FDA's Clinical Data
Mentors: Minjun Chen (NCTR/FDA) and Ruili Huang (NCATS)

Quantitative high throughput screening for drugs targeting COP1 to promote T cell function.
Mentors: Weiming Ouyang (CDER/FDA) and Menghang Xia (NCATS)

Evaluation of three-dimensional (3D) immunocompetent skin fibrosis model for cell-based therapy products
Mentors: Kyung Sung (CBER/FDA), Mark Ferrer (NCATS) and Yi Wei Lim (NCATS)

No second choice project. Only consider me for my first choice project.

reset

Please select your third choice project:

* must provide value

Leveraging AI to Enhance Drug Safety Predictions through Integrated Analysis of Tox21 Data and FDA's Clinical Data
Mentors: Minjun Chen (NCTR/FDA) and Ruili Huang (NCATS)

Quantitative high throughput screening for drugs targeting COP1 to promote T cell function.
Mentors: Weiming Ouyang (CDER/FDA) and Menghang Xia (NCATS)

Evaluation of three-dimensional (3D) immunocompetent skin fibrosis model for cell-based therapy products
Mentors: Kyung Sung (CBER/FDA), Mark Ferrer (NCATS) and Yi Wei Lim (NCATS)

No third choice project. Only consider me for my first, or first and second, choice projects.

reset

If you are not accepted into the TSIF program, would you be interested in having your CV and application information forwarded for other NCATS postdoctoral opportunities?

* must provide value

Yes

reset

	Name (First and Last)	Email	Phone Number
1
2
3

Curriculum Vitae (CV)

* must provide value

Upload file

Personal Statement: In narrative form, describe your research interests and goals and how these relate to the fields of translational science and regulatory and drug development science. Additionally, indicate how your goals are aligned with one or more of the TSIF projects listed on the TSIF web-page. Please also provide insight into your short- and long-term career goals, and explain how the TSIF program will help you in achieving those goals. Please limit your personal statement to two typed, single-spaced pages and use 12-point font and 1" margins (approximately 1,000 words).

* must provide value

Upload file

Proof of terminal degree: If you have already obtained your terminal degree by the date of this application, please upload a copy of your graduate transcript or diploma, here, as proof of the degree (Ph.D., M.D., etc.).

* must provide value

Upload file

Proof of graduation: If you have not obtained your terminal degree by the date of this application, please submit documentation here that you will obtain the degree before September 8, 2025, the start-date of the TSIF fellowship. Examples include but are not limited to: written assurance from dissertation committee chair (for Ph.D. candidates) or the dean of the school (for M.D. candidates).

* must provide value

Upload file

Proof of citizenship: Permanent residents of the United States must submit proof of eligibility for citizenship. The I-551 stamp in a passport is acceptable; "Employment Authorization" documents are not acceptable.

* must provide value

Upload file

I certify that, to the best of my knowledge, the provided information is true and accurate.

* must provide value

Add signature

OMB# 0925-0761
Expiration Date: 07/31/2025

Collection of this information is authorized by The Public Health Service Act, Section 479 (42 USC 287). The information collected in this application will be used to facilitate the acceptance and onboarding of applicants. Rights of participants are protected by The Privacy Act of 1974. The information you provide will be included in a Privacy Act system of records, and will be used and may be disclosed for the purposes and routine uses described and published in the following System of Records Notice (SORN): 09-25-0014 - Clinical Research: Student Records, HHS/NIH/OD/OIR/OE. Participation is voluntary, and there are no penalties for not participating or withdrawing at any time. The information collected will be kept private to the extent provided by law. Names and other identifiers will not appear in any report. Information provided will be combined for all participants and reported as summaries.

Public reporting burden for this collection of information is estimated to average 60 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0761). Do not return the completed form to this address.

Selection for the fellowship will be based solely on merit, with no discrimination for non-merit reasons, such as race, color, gender, national origin, age, religion, sexual orientation, or physical or mental disability. NIH and FDA provide reasonable accommodations to applicants with disabilities. If you need reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be handled on a case-by-case basis.

THE NIH/NCATS AND FDA ARE EQUAL OPPORTUNITY EMPLOYERS.

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.